Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites.

Ruenitz, P C; Thompson, C B; Srivatsan, V

Ruenitz, P C; Thompson, C B; Srivatsan, V.

Affiliation

Ruenitz PC; College of Pharmacy, University of Georgia, Athens 30602.

J Steroid Biochem ; 33(3): 365-9, 1989 Sep.

Article in En | MEDLINE | ID: mdl-2550704

Subject(s)

Breast Neoplasms/pathology; Estrogen Antagonists/pharmacology; Nitromifene/pharmacology; Pyrrolidines/pharmacology; 3',5'-Cyclic-AMP Phosphodiesterases/metabolism; Binding, Competitive; Breast Neoplasms/metabolism; Calmodulin/antagonists & inhibitors; Cell Division/drug effects; Enzyme Activation/drug effects; Estrogen Antagonists/metabolism; Humans; Nitromifene/metabolism; Receptors, Estrogen/drug effects; Receptors, Estrogen/metabolism; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Breast Neoplasms / Estrogen Antagonists / Nitromifene Limits: Humans Language: En Journal: J Steroid Biochem Year: 1989 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links